Targeting a Q4 2021 launch, the Company is preparing for a series of surgical labs, to validate the final specs for FDA compliant US manufacturing, and the protocols for training. Demand is positive from prominent Orthopedic practices, Universities, insurance carriers, hospital systems and surgeons in professional sports.
COMPREHENSIVE SURGICAL DIAGNOSTICS AT THE MICRO SCALE
FLEXIBILITY & PRECISE STEERING ELIMINATE TRAUMA + EXPAND ACCESS
HD-GUIDED MICRO REPAIRS & BIOLOGICS EARN MDs ATTRACTIVE FEES
STERILE DEVICES (TRULY DISPOSABLE COST) WITHIN PROCEDURE BUDGETS
EXTENSIVE INTELLECTUAL PROPERTY
ROBUST LAUNCH PARTNERS & U.S. MANUFACTURING
CLEAR PATH THROUGH REGULATORY AND LAUNCH